Voriconazole is delivered from antifungal-loaded bone cement knee

Clinical Orthopaedics and Related Research

Volumn 471, Issue 1, 2013, Pages 195-200

  Miller, Ryan B ^a   McLaren, Alex C ^a,b   Pauken, Christine ^b   Clarke, Henry D ^c   McLemore, Ryan ^a,b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b Arizona State University   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; UNCLASSIFIED DRUG; VORICONAZOLE; VORICONAZOLE LOADED BONE CEMENT;

COMPRESSIVE STRENGTH; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 84871614313     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2463-8     Document Type: Conference Paper

References (16)

1. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385-5394.
2. Cunningham B, McLaren A, Pauken C, McLemore R. Liposomal formulation increases local delivery of amphotericin from bone cement. Clin Orthop Relat Res. 2012 Mar 31 [Epub ahead of print]. DOI: 10.1007/s11999-012-2317-4.
3. Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006;37(Suppl 1):S95-S104.
4. Eiden C, Mathieu O, Peyrière H, Hillaire-Buys D, Cociglio M. Simultaneous quantification of voriconazole and its N-oxide metabolite in human plasma by an easy and rapid isocratic LC nethod with UV detection. Chroma. 2008;67:275-280.
5. Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22:902-908.
6. Grimsrud C, Raven R, Fothergill AW, Kim HT. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics. 2011;34:e378-381.
7. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79-85.
8. Harmsen S, McLaren AC, Pauken C, McLemore R. Amphotericin B is cytotoxic at locally delivered concentrations. Clin Orthop Relat Res. 2011;469:3016-3021.
9. Kweon C, McLaren AC, Leon C, McLemore R. Amphotericin B delivery from bone cement increases with porosity but strength decreases. Clin Orthop Relat Res. 2011;469:3002-3007.
10. Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, Jewesson PJ. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001;44:383-386.
11. McLaren A, McLemore R, Gutierrez F, Martin M. Local antimicrobial treatment. In: Cierney G III, McLaren A, Wongworowat M, eds. Orthopaedic Knowledge Update: Musculoskeletal Infection. Rosemont, IL, USA: American Academy of Orthopaedic Surgeons; 2009:95-117
12. McLaren A, Nugent M, Economopoulos K, Kaul H, Vernon B, McLemore R. Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. Clin Orthop Relat Res. 2009;467:1693-1698.
13. Miller R, McLaren A, Leon C, McLemore R. Mixing method affects elution and strength of high dose ALBC. Clin Orthop Relat Res. 2012 May 3 [Epub ahead of print]. DOI: 10.1007/s11999-012-2351-2.
14. Rouse MS, Heijink A, Steckelberg JM, Patel R. Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clin Orthop Relat Res. 2011;469:1466-1469.
15. Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009;43:1606-1615.
16. Silverberg D, Kodali P, Dipersio J, Acus R, Askew M. In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement. Clin Orthop Relat Res. 2002;403:228-231.